Development of biomarkers of genitourinary cancer using mass spectrometry-based clinical proteomics
Development of biomarkers of genitourinary cancer using mass spectrometry-based clinical proteomics
About this item
Full title
Author / Creator
Publisher
China (Republic : 1949- ): Elsevier Taiwan LLC
Journal title
Language
English
Formats
Publication information
Publisher
China (Republic : 1949- ): Elsevier Taiwan LLC
Subjects
More information
Scope and Contents
Contents
Prostate, bladder and kidney cancer are the three most common types of genitourinary cancer in the world. Of these, prostate and bladder cancers are within the top 10 most common cancers in men. Notably, kidney cancer causes no obvious symptoms in the early stages. To satisfy clinical-management requirements, researchers have developed numerous bio...
Alternative Titles
Full title
Development of biomarkers of genitourinary cancer using mass spectrometry-based clinical proteomics
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9296213
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9296213
Other Identifiers
ISSN
1021-9498
E-ISSN
2224-6614
DOI
10.1016/j.jfda.2018.09.005
